PERSPECTA

News from every angle

← Back to headlines

ImmunityBio Faces Securities Fraud Class Action Lawsuit

Investors in ImmunityBio, Inc. (IBRX) are facing a May 26, 2026, deadline to participate in a securities fraud class action lawsuit against the company.

18 Apr, 15:20 — 18 Apr, 15:20
PostShare

Sources

Showing 1 of 1 sources
globe-and-mailHigh121d ago

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Deadline in Securities Fraud Class Action Lawsuit - The Globe and Mail

ImmunityBio, Inc. (IBRX) Investors: May 26, 2026, Deadline in Securities Fraud Class Action Lawsuit  The Globe and Mail

Read full article →

Related Stories

West Nile Fever Cases and Fatalities Reported in Serbia and North Macedonia

3h ago

Metro Manila Inundated by Heavy Monsoon Rains

5h ago

AstraZeneca Halts Lung Cancer Drug Trial

6h ago

Priessnitz Spa Addresses Outbreak of Digestive Problems, Hygiene Registers 111 Cases

7h ago